A team of researchers led by NYU Tandon School of Engineering's Weiqiang Chen has developed a miniature device that could transform how blood cancer treatments are tested and tailored for patients.
Save Tenured/Tenure-Track Faculty Positions in Neural-Cell-and-Tissue Engineering and Regeneration - Click to add the job to your shortlist NYU Tandon seeks faculty in Neural-Cell-and-Tissue ...
Hosted on MSN
Engineers create first immunocompetent leukemia device for CAR T immunotherapy screening
A team of researchers led by NYU Tandon School of Engineering's Weiqiang Chen has developed a miniature device that could transform how blood cancer treatments are tested and tailored for patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results